Sravan Eduru is a purpose-driven biopharma executive with over 19 years of global leadership experience across R&D, regulatory, commercial strategy, and launch in the industry. With a proven track record of advancing 7 biologics and 2 NCEs from drug discovery & development through global approvals and launches in Oncology, Immunology, Respiratory, and Cardio-Metabolic TAs, he excels at driving cross-functional programs, innovation and portfolio strategy. As a Global Program Lead, 'CEO of the assets', he has led global program core teams (GPTs), shaped 20+ successful engagements with regulatory and HTA bodies, forged strong KOL, payer, and advocacy networks on lifecycle evidence planning. Sravan is an Angel Investor & AI strategy Advisor, with expertise in BD&L, AI-driven business transformation, and digital innovation with passion for building the future of healthcare. His education includes a Master of Pharmacy (in Pharmacology) at Manipal, Executive MBA (IIM, Bangalore), leadership training (Harvard), and AI for Business Strategy (MIT, Sloan School of Management).